Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

KLRS holding history

Kalaris Therapeutics, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KLRS overviewAll 13F holders of KLRSFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of KLRS by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−82,955−100.0%Sold outHolders
Q4 202582,955$700.1K0.1%00.0%UnchangedHolders
Q3 202582,955$479.5K<0.1%00.0%UnchangedHolders
Q2 202582,955$221.5K<0.1%00.0%UnchangedHolders
Q1 202582,955$666.1K0.1%00.0%UnchangedConverted for a 1-for-23 splitHolders
Q4 20241,907,969$801.3K0.1%00.0%UnchangedHolders
Q3 20241,907,969$1.54M0.1%00.0%UnchangedHolders
Q2 20241,907,969$1.38M0.1%00.0%UnchangedHolders
Q1 20241,907,969$1.44M0.1%00.0%UnchangedHolders
Q4 20231,907,969$1.30M<0.1%00.0%UnchangedHolders
Q3 20231,907,969$4.10M0.2%00.0%UnchangedHolders
Q2 20231,907,969$6.49M0.2%00.0%UnchangedHolders
Q1 20231,907,969$7.52M0.3%00.0%UnchangedHolders
Q4 20221,907,969$9.79M0.4%00.0%UnchangedHolders
Q3 20221,907,969$15.1M0.6%+1,084,598+131.7%AddedHolders
Q2 2022823,371$3.21M0.1%00.0%UnchangedHolders
Q1 2022823,371$5.56M0.2%00.0%UnchangedHolders
Q4 2021823,371$10.7M0.2%−13,541−1.6%ReducedHolders
Q3 2021836,912$21.0M0.4%−747,181−47.2%ReducedHolders
Q2 20211,584,093$31.3M0.5%−359,494−18.5%ReducedHolders
Q1 20211,943,587$45.5M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.